GDC--0084, page-23

It makes perfect sense that a company with a compound attracting such interest as GDC-0084 is, that this company would only take the required funding during the expanding attention and growing value of it’s asset/s enough to step it through its value expansions.

Any desire to fully fund for the future at this time would show a very simple understanding of the dynamics at play here.

Luckily we have a very astute management team and they are aware of these infection points and are appropriately weighting the required finance dynamics with asset growth.

The current management continue to show a very astute ability to gauge timing and deadlines, surprise with credible collaborations with world class cancer research bodies and given the complexities of trials this is very encouraging.

Happy to hold and buy more.